Cormorant Global Healthcare Master Fund reports sale of $1.74 million in Corbus Pharmaceuticals shares
CRBP•Cormorant Asset Management reported selling 425,000 Corbus Pharmaceuticals shares on Oct. 29, 2026, at $4.1006 per share, leaving indirect beneficial ownership of 1,919,971 shares.
1. Reported share sale
A Nov. 2, 2026, filing reported that Cormorant Asset Management sold 425,000 Corbus Pharmaceuticals common shares on Oct. 29 at $4.1006 per share. The sale left indirect beneficial ownership of 1,919,971 shares. The filing listed managing member Bihua Chen and the Cormorant reporting entities as former 10% owners.
